The Endocannabinoid System is a naturally occurring biochemical communication system believed to be used to help regulate many neurological and physiological processes. This system, which until recently was unknown to scientists and doctors, is now recognized as having receptors in the brain and throughout the body.
In their paper titled, “The Endocannabinoid System as an Emerging Target of Pharmacotherapy”, doctors and researches Pál Pacher, Sándor Bátkai and George Kunos, write,
“In the past decade, the endocannabinoid system has been implicated in a growing number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson’s and Huntington’s disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few.”
For those individuals seeking holistic alternatives to chemically derived pharmaceuticals, phytocannabinoids may offer hope and healing where other treatments may have failed or delivered unwanted side effects.
As researchers continue to uncover the workings of the endocannabinoid system as well as other systems within the body, we hope that this work will lead to additional medically accepted treatment options utilizing phytochemicals such as CBD, THC, and others.
For additional information on the paper quoted above, please visit: